KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Long-Term Deferred Tax: 2012-2019

Historic Long-Term Deferred Tax for Ionis Pharmaceuticals (IONS) over the last 4 years, with Dec 2019 value amounting to $305.6 million.

  • Ionis Pharmaceuticals' Long-Term Deferred Tax rose 7.98% to $307.7 million in Q3 2020 from the same period last year, while for Sep 2020 it was $307.7 million, marking a year-over-year increase of 7.98%. This contributed to the annual value of $305.6 million for FY2019, which is 5.08% up from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Long-Term Deferred Tax of $305.6 million as of FY2019, which was up 5.08% from $290.8 million recorded in FY2018.
  • Over the past 5 years, Ionis Pharmaceuticals' Long-Term Deferred Tax peaked at $305.6 million during FY2019, and registered a low of $290.8 million during FY2018.
  • In the last 2 years, Ionis Pharmaceuticals' Long-Term Deferred Tax had a median value of $298.2 million in 2018 and averaged $298.2 million.
  • Data for Ionis Pharmaceuticals' Long-Term Deferred Tax shows a peak YoY climbed of 5.08% (in 2019) over the last 5 years.
  • Over the past 2 years, Ionis Pharmaceuticals' Long-Term Deferred Tax (Yearly) stood at $290.8 million in 2018, then climbed by 5.08% to $305.6 million in 2019.